Skip to main content
. 2012 Nov 2;6:385–393. doi: 10.2147/BTT.S23561

Figure 3.

Figure 3

Measured glomerular filtration rate (GFR) by month 12 in patients with and without rejection in BENEFIT.

Abbreviations: AR, acute rejection; BENEFIT, Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial; CsA, cyclosporine; LI, less intensive; MI, more intensive.